HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

PRGO

Perrigo Company plc (NYSE)

Healthcare — Drug Manufacturers - Specialty & Generic

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

None 4 analysts
$10.31
$-0.08 (-0.77%)
Target: $16.50 (60.0%)
Sign in to add PRGO to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$1.43B
P/E Ratio (TTM)-
Forward P/E4.36
EPS (TTM)$-12.93
Dividend Yield11.25%
Profit Margin-43.50%
Revenue Growth-7.20%
ROE-52.23%
Debt/Equity153.22
Recommendation None
Analyst Target$16.50
Analysts4
Indexes NYSE

Technical Indicators

RSI (14)36.5
Beta0.52
SMA 20-
SMA 40-
52-Week High$28.44
52-Week Low$9.23
50-Day Avg$10.96
200-Day Avg$14.03
Avg Volume$3.23M
Volume$2.90M

Performance Analysis

NEUTRAL

PRGO presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($9.23), which could present a value opportunity.
~ RSI at 36.5 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 7.2% year-over-year.
- Operating at a loss with -43.5% margin.
~ Wall Street consensus is "none" from 4 analysts.
+ Average analyst target of $16.50 implies 60.0% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:27 UTC

Back to Screener Export Report